Ludwig Enterprises (LUDG) Cash from Investing Activities (2025)

Ludwig Enterprises (LUDG) posted Cash from Investing Activities of -$411.0 for Q4 2025, up 94.95% on a QoQ basis from -$8135.0 in Q3 2025.

Ludwig Enterprises (LUDG) Cash from Investing Activities (2025) Analysis & Trends

Ludwig Enterprises' Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$411.0 for Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Activities (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	-20.32 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	-185.00 Mn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	-917.00 Mn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	-591.00 Mn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	-92.80 Mn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-298.50 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	-2.50 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	-475.32 Mn
10	Ludwig Enterprises	3.27 Mn	3.27 Mn	-	-

Download Data